The object
Simon Fredriksson co-invented proximity ligation assays, which convert a protein-recognition event into a DNA signal that can be amplified and measured. The EPO recognizes the platform's diagnostic impact, and a 2026 interview identifies Fredriksson as Pixelgen's CEO and traces his proteomics work.
01
What Simon did
Co-invented the proximity ligation assay platform for sensitive protein detection using DNA-linked affinity probes.
02
Why it matters
The platform combines dual-recognition specificity with DNA amplification to enable sensitive protein assays for research and diagnostics.
03
Living-status check
A dated April 28, 2026 interview identifies Fredriksson as Pixelgen CEO and traces his continuing proteomics work.